MeSH Browser

MeSH Heading: Mesalamine
Tree Number(s): D02.241.223.100.050.300.500; D02.241.223.100.300.595.100.540; D02.241.511.390.595.100.540; D02.455.426.559.389.127.020.452.750; D02.455.426.559.389.127.281.595.100.540; D02.455.426.559.389.657.410.595.100.540
Unique ID: D019804
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D019804
Scope Note: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
Entry Term(s): 5-Aminosalicylate; 5-Aminosalicylic Acid; Asacol; Asacolon; Ascolitin; Canasa; Claversal; Fivasa; Lixacol; Mesalamine Hydrochloride; Mesalamine Monosodium Salt; Mesalazine; Mesasal; Novo-5 ASA; Pentasa; Rowasa; Salofalk; m-Aminosalicylic Acid; meta-Aminosalicylic Acid
Pharm Action: Anti-Inflammatory Agents, Non-Steroidal
Related Numbers: 35589-28-7; 6291-36-7; 89-57-6
Previous Indexing: Aminosalicylic Acids (1981-1997)
Public MeSH Note: 98; MESALAMINE was indexed under AMINOSALICYLIC ACIDS 1981-97
History Note: 98; use MESALAMINE (NM) 1981-97
Entry Combination: analogs & derivatives:Aminosalicylic Acids
Date Established: 1998/01/01
Date of Entry: 1997/06/20
Revision Date: 2017/01/17

Entry Combination: analogs & derivatives:Aminosalicylic Acids
Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analysis (AN)

antagonists & inhibitors (AI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

economics (EC)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Concept UI: M0029386
Related Numbers: 35589-28-7; 6291-36-7; 89-57-6
Scope Note: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
Terms: Mesalamine Preferred Term
Term UI T058909
Date01/01/1999
LexicalTag NON
ThesaurusID; 5-Aminosalicylic Acid
Term UI T058907
Date12/26/1996
LexicalTag NON
ThesaurusID; meta-Aminosalicylic Acid
Term UI T058910
Date12/26/1996
LexicalTag NON
ThesaurusID NLM (1998); m-Aminosalicylic Acid
Term UI T058911
Date12/26/1996
LexicalTag NON
ThesaurusID; Mesalazine
Term UI T058915
Date12/26/1996
LexicalTag NON
ThesaurusID

Mesalamine MeSH Descriptor Data 2024